M&A TRANSACTION · 2023
Enzo Biochem's Clinical Lab Business acquired by LabCorp
$112.8M· 1.50x revenue
Target
Enzo Biochem's Clinical Lab Business
Acquirer
LabCorp
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$74.4M
EBITDA
—
Deal Value
$112.8M
EV/EBITDA
—
Context
This $112.8M acquisition of Enzo Biochem's Clinical Lab Business by LabCorp sits in the laboratory services sub-vertical. LabCorp is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Enzo Biochem's Clinical Lab Business acquisition.